期刊文献+

用培美曲塞对晚期肺大细胞癌患者进行二线化疗的效果及安全性

下载PDF
导出
摘要 目的:分析用培美曲塞对晚期肺大细胞癌患者进行二线化疗的效果及安全性。方法:选取2018年1月至2018年12月期间山西省大同市第三人民医院收治的46例晚期肺大细胞癌患者作为研究对象。按照入院顺序的先后将其平均分为对照组和观察组。使用多西他赛对对照组患者进行化疗,使用培美曲塞对观察组患者进行化疗。化疗结束后,对比两组患者化疗的效果和化疗不良反应的发生情况。结果:与对照组患者相比,观察组患者化疗的总有效率较高,其化疗不良反应的总发生率较低,P<0.05。结论:用培美曲塞对晚期肺大细胞癌患者进行二线化疗的效果较好、安全性较高。
作者 何捷
出处 《当代医药论丛》 2019年第23期116-117,共2页
  • 相关文献

参考文献7

二级参考文献84

  • 1FERLAY J, SHIN H R, BRAY F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [ J ] . Int J Cancer, 2010, 127: 2893-2917.
  • 2AZZOLI C G, BARKER S J R, TEMIN S, et al. American Society of Clinical Oncology Clinical Practice guideline update on chemotherapy for stage IV non-small-cell lung cancer [ J ] . J Clin Oncol, 2009, 27: 6251-5266.
  • 3ZINNER R G, FOSSELLA F V, GLADISH G W, et al. Phase 1T study of pemetrexed in combination with carboplatin in the first-line treatment of advanced non-small cell lung cancer [ J ] . Cancer, 2005, 104: 2449-2456.
  • 4JONES R J, TWELVES C J. Pemetrexed: a muhitargeted antifolate (ALIMTA), LY-231514) [ J ] . Expert Rev Anticancer Ther, 2002, 2(1): 13-22.
  • 5DELBALDO C, MICHIELS S, SYZ N, et al. Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis [ J ] . JAMA, 2004, 292: 470-484.
  • 6HANNA N, SHEPHERD F A, FOSSELLA F V, et al. Randomized phase llI trim of pemetrxed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy [ J ] . J Clin Oncol, 2004, 22(9): 1589- 1597.
  • 7SCAGLIOTTI G V, PARIKH P, VOL PAWEL J, et al. Phase m study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced stage non-small cell lung cancer [ J ] . J Clin Oncal, 2008, 26(21): 3543-3551.
  • 8SCAGLIOTTI G V, PARK K, PATIL S, et al. Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaive patients with advanced non-small cell lung cancer: a risk-benefit analysis of a large phase 111 study [ J ] . Euro J Cancer, 2009, 13: 2298-2303.
  • 9Parkin DM. Global cancer statistics in the year 2000[J]. Lancet Oncoi,2001,2(9) :533- 543.
  • 10Wang T, Nelson RA, Bogardus A, et al. Five year lung cancer survival:which advanced stage nonsmall cell lung cancer patients attain long-term survival? [J]. Cancer, 2010,116 (6) : 1518-1525.

共引文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部